MultipleSclerosisCentral.com

See all of our health sites at www.HealthCentral.com
Sunday, July 20, 2008

Hepatitis B vaccination not tied to MS in children

Tuesday, Dec. 4, 2007; 4:27 AM

NEW YORK (Reuters Health) - Vaccinating against hepatitis B virus (HBV) does not increase a child's risk of developing multiple sclerosis (MS), according to a study released Monday.

Most prior studies have not shown a link between the use of HBV vaccine and MS in children, Dr. Yann Mikaeloff, from Hopital Bicetre, Le Kremlin Bicetre, and colleagues note in the Archives of Pediatrics and Adolescent Medicine.

However, one study, which featured a slightly longer follow-up period than the others, did suggest a significant association. This led to public concerns about the safety of the HBV vaccine and a drop in vaccination rates in many countries.

Furthermore, many of the earlier studies had "methodologic" problems, the investigators say, which may have prevented them from reaching definitive conclusions.

Against this backdrop, Mikaeloff and colleagues assessed 143 children who developed MS before age 16, with a first episode of the disease occurring between 1994 and 2003. Each patient was matched to an average of eight control participants from the general French population who were the same age and sex and lived in the same location but did not have MS.

In the three years before the first episode of MS, roughly 32 percent of both the 143 children with MS and the 1,122 controls were vaccinated against hepatitis B.

Mikaeloff and colleagues report that vaccination against hepatitis B within the three-year study period was not associated with an increased rate of a first episode of MS.

"The rate was also not increased for hepatitis B vaccination within six months of the index date or at any time since birth or as a function of the number of injections or the brand of hepatitis B vaccine."

In a related editorial, Dr. Frederick P. Rivara and Dr. Dimitri A. Christakis, at the University of Washington and editors of the Archives of Pediatrics and Adolescent Medicine, write: "We have published (this study) both because of the rigor of the research and because of the need to reassure a public that is increasingly wary of vaccination."

"Going forward, we hope that the process of scientific discovery proceeds in a rigorous and thoughtful way that will increase the public's health and not harm it."

SOURCE: Archives of Pediatrics and Adolescent Medicine, December 2007.


Copyright © 2007 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

Ask a Question

Get answers from our experts and community members.

Answer a Question

Is a low grade fever with fatigue normal?

Answer This View all questions >
Healthcare 08